TeresaLynnHelstenMD(She/Her)

Oncology • La Jolla, CA

Breast Cancer

UC San Diego Health Comprehensive Breast Center Moores Cancer Center

Join to view full profile

Dr. Helsten is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Helsten's full profile

Already have an account?

Office
3855 Health Sciences Dr
#0987
La Jolla, CA 92093
Phone+1 858-249-3249

Fax+1 858-249-3250

Education & Training

University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1998 - 2002
University of California, Davis, School of MedicineClass of 1998

Certifications & Licensure

CA State Medical License 2000 - 2026

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin Start of enrollment: 2011 Aug 01
Terminated
Phase 1
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer Start of enrollment: 2012 Apr 01
Terminated
Phase 2
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer Start of enrollment: 2013 Oct 22
Active, not recruiting
Phase 1, Phase 2
A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer Start of enrollment: 2015 Aug 01
Completed
Phase 2
Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations Start of enrollment: 2017 Apr 01
Withdrawn
Phase 2
Join now to see all

Publications & Presentations

PubMed

Let's TOC Fertility: A stepped wedge cluster randomized controlled trial of the Telehealth Oncofertility Care (TOC) intervention in children, adolescent and young adul...
Sally A D Romero, Lauren Au, Ricardo E Flores-Ortega, Teresa Helsten, Helen Palomino
Contemporary Clinical Trials. 2024-06-01
19 citations
AI-Generated Draft Replies Integrated Into Health Records and Physicians' Electronic Communication.
Ming Tai-Seale, Sally L Baxter, Florin Vaida, Amanda Walker, Amy M Sitapati
JAMA Network Open. 2024-04-01
2 citations
Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer.
Rebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, Richard B Schwab, Emily I Pittman
Breast Cancer Research. 2024-03-13